DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Total Expenditure History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Expenditure | ₹6,391 Cr | ₹5,639 Cr | ₹5,398 Cr | ₹5,079 Cr | ₹4,108 Cr |
What is the latest Total Expenditure of DIVIS LABORATORIES ?
Year | Total Expenditure |
---|---|
Mar2025 | ₹6,391 Cr |
Mar2024 | ₹5,639 Cr |
Mar2023 | ₹5,398 Cr |
Mar2022 | ₹5,079 Cr |
Mar2021 | ₹4,108 Cr |
How is Total Expenditure of DIVIS LABORATORIES Trending?
Years | Total Expenditure | % Change | |
---|---|---|---|
Mar2025 | ₹6,391 Cr | 13.34 | |
Mar2024 | ₹5,639 Cr | 4.46 | |
Mar2023 | ₹5,398 Cr | 6.29 | |
Mar2022 | ₹5,079 Cr | 23.62 | |
Mar2021 | ₹4,108 Cr | - |
Compare Total Expenditure of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹177,319.5 Cr | 0.4% | -2% | 37.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,466.0 Cr | 1.7% | 2% | -0.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹127,538.0 Cr | 6% | 10.5% | 13.6% | Stock Analytics | |
CIPLA | ₹125,993.0 Cr | 6.8% | 4.6% | -0.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,795.0 Cr | 4.2% | 1.3% | -6.7% | Stock Analytics | |
MANKIND PHARMA | ₹105,363.0 Cr | -1.9% | 9.9% | 23.7% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 0.4% |
-2% |
37.3% |
SENSEX | -1% |
-3.2% |
1.6% |
You may also like the below Video Courses